Volume 21 Issue 7
Jul.  2023
Turn off MathJax
Article Contents
WU Mengwei, HU Yidong, YANG Liu, HU Kai, SU Hao. Clinical experience of intravenous removal of lead electrodes in middle-aged and elderly patients with delayed infection of cardiac implantable electronic device[J]. Chinese Journal of General Practice, 2023, 21(7): 1130-1133. doi: 10.16766/j.cnki.issn.1674-4152.003066
Citation: WU Mengwei, HU Yidong, YANG Liu, HU Kai, SU Hao. Clinical experience of intravenous removal of lead electrodes in middle-aged and elderly patients with delayed infection of cardiac implantable electronic device[J]. Chinese Journal of General Practice, 2023, 21(7): 1130-1133. doi: 10.16766/j.cnki.issn.1674-4152.003066

Clinical experience of intravenous removal of lead electrodes in middle-aged and elderly patients with delayed infection of cardiac implantable electronic device

doi: 10.16766/j.cnki.issn.1674-4152.003066
Funds:

 2018H176

 KF2018005

  • Received Date: 2022-03-04
    Available Online: 2023-08-28
  •   Objective  To retrospectively analyze the safety and feasibility of transvenous lead extraction (TLE) in middle-aged and elderly with delayed infection of cardiac implantable electronic device (CIED).  Methods  A total of 60 TLE patients with delayed infection of CIED hospitalized at the First Hospital of the University of Science and Technology of China (Anhui Provincial Hospital) from May 2015 to May 2021 were collected. The patients were divided into the younger group (< 70 years old, n=32) and the middle-aged and elderly group (≥70 years old, n=28) according to the age. The baseline data, surgical data and postoperative complications of the patients were collected to analyze the efficacy and safety of transvenous electrode removal in the two groups.  Results  Among the 60 patients enrolled, the age of the middle-aged and elderly group was (77.5±4.7) years old with 18 male patients (64.3%, 18/28), the age of the younger group was (57.1±8.7) years old with 23 male patients (71.9%, 23/32). The differences of two groups on complications for patients such as atrial fibrillation [9.4% (3/32) vs. 35.7% (10/28)], hypertension [3.1% (1/32) vs. 53.6% (15/28)], coronary heart disease [3.1% (1/32) vs. 25.0% (7/28)] were statistically significant (all P<0.05). There was no significant difference in complication rate [3.1% (1/32) vs. 7.1% (2/28), P=0.476] and complete surgical success rate [96.9% (31/32) vs. 96.4% (27/28), P=0.923] between the two groups.  Conclusion  The safety and feasibility of TLE in middle-aged and elderly patients with delayed infection of CIED is safe and feasible.

     

  • loading
  • [1]
    BLOMSTRÖM-LUNDQVIST C, TRAYKOV V, ERBA P A, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)[J]. Europace, 2020, 22(4): 515-549. doi: 10.1093/europace/euz246
    [2]
    POLEWCZYK A, JACHECĆ W, POLEWCZYK M, et al. Early, delayed and late cardiac implantable electronic device infections: do the timing of onset and pathogens matter?[J]. J Clin Med, 2022, 11(14): 3929. doi: 10.3390/jcm11143929
    [3]
    BONGIORNI M G, BURRI H, DEHARO J C, et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS[J]. Europace, 2018, 20(7): 1217. doi: 10.1093/europace/euy050
    [4]
    冯天捷, 翁思贤, 周彬, 等. 心律植入装置迟发感染的临床分析[J]. 中国分子心脏病学杂志, 2021, 21(1): 3692-3696. doi: 10.16563/j.cnki.1671-6272.2021.02.005

    FENG T J, WENG S X, ZHOU B, et al. Clinic analysis of late infection in patients undergoing implantation of cardiac implantable electronic device[J]. Molecular Cardiology of China, 2021, 21(1): 3692-3696. doi: 10.16563/j.cnki.1671-6272.2021.02.005
    [5]
    BOARESCU P M, ROŞIAN A N, ROŞIAN Ş H. Transvenous lead extraction procedure-indications, methods, and complications[J]. Biomedicines, 2022, 10(11): 2780. doi: 10.3390/biomedicines10112780
    [6]
    沈萍. 了解我国人口老龄化社会现状, 关爱身边老人[J]. 中国医学人文评论, 2015: 48-51. https://xuewen.cnki.net/CCND-SHHU202211020013.html

    SHEN P. Understanding the current situation of population aging society in China and caring for the elderly around[J]. Chinese Medical Humanities Review, 2015: 48-51. https://xuewen.cnki.net/CCND-SHHU202211020013.html
    [7]
    DIEMBERGER I, SEGRETI L, RINALDI C A, et al. Transvenous lead extraction in patients with cardiac implantable device: the impact of systemic and local infection on clinical outcomes-an ESC-EHRA ELECTRa (European lead extraction controlled) registry substudy[J]. Biology(Basel), 2022, 11(4): 615.
    [8]
    STEFANǸCZYK P, NOWOSIELECKA D, POLEWCZYK A, et al. Safety and effectiveness of transvenous lead extraction in patients with infected Cardiac Resynchronization Therapy Devices; Is it more risky than extraction of other systems?[J]. Int J Environ Res Public Health, 2022, 19(10): 5803. doi: 10.3390/ijerph19105803
    [9]
    SIDHU B S, GOULD J, BUNCE C, et al. The effect of centre volume and procedure location on major complications and mortality from transvenous lead extraction: an ESC EHRA EORP European Lead Extraction ConTRolled ELECTRa registry subanalysis[J]. Europace, 2020, 22(11): 1718-1728. doi: 10.1093/europace/euaa131
    [10]
    DESIMONE D C, SOHAIL M R, MULPURU S K. Contemporary management of cardiac implantable electronic device infection[J]. Heart, 2019, 105(12): 961-965.
    [11]
    VASILEV S. Strategies for prevention of surgical site infection in patients with CIED Implantation: a literature review[J]. Cureus, 2021, 13(1): e13021. DOI: 10.7759/cureus.13021.
    [12]
    RAO A, GARNER D, STARCK C, et al. Knowledge gaps, lack of confidence, and system barriers to guideline implementation among European physicians managing patients with CIED lead or infection complications: a European Heart Rhythm Association/European Society of Cardiology educational needs assessment survey[J]. Europace, 2020, 22(11): 1743-1753. doi: 10.1093/europace/euaa218
    [13]
    MILMAN A, ZAHAVI G, MEITUS A, et al. Predictors of short-term mortality in patients undergoing a successful uncomplicated extraction procedure[J]. J Cardiovasc Electrophysiol, 2020, 31(5): 1155-1162. doi: 10.1111/jce.14436
    [14]
    CALLAHAN T D, MARTIN D O. Quantifying risk after transvenous lead extraction[J]. J Cardiovasc Electrophysiol, 2020, 31(5): 1163-1165. doi: 10.1111/jce.14435
    [15]
    BORIANI G, VITOLO M, WRIGHT D J, et al. Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRXTM antibacterial envelope[J]. Europace, 2021, 23(23 Suppl 4): iv33-iv44. DOI: 10.1093/europace/euab126.
    [16]
    ZHOU X, ZE F, LI X, et al. Efficacy and safety of transvenous lead extraction in the Chinese octogenarian patients[J]. Clin Cardiol, 2021, 44(7): 971-977. doi: 10.1002/clc.23629
    [17]
    GIANNOTTI SANTORO M, SEGRETI L, ZUCCHELLI G, et al. Transvenous lead extraction: efficacy and safety of the procedure in octogenarian patients[J]. Pacing Clin Electrophysiol, 2020, 43(4): 382-387. doi: 10.1111/pace.13896
    [18]
    周高亮, 乔勇, 冯俊, 等. 经静脉拔除感染的心律植入装置: 一项单中心回顾性观察性研究[J]. 中国心血管病研究, 2022, 20(9): 801-806. https://www.cnki.com.cn/Article/CJFDTOTAL-XXGZ202209004.htm

    ZHOU G L, QIAO Y, FENG J, et al. Removal of infected cardiac implantable electronic device through vein: a single center retrospective observational study[J]. Chinese Journal of Cardiovascular Research, 2022, 20(9): 801-806. https://www.cnki.com.cn/Article/CJFDTOTAL-XXGZ202209004.htm
    [19]
    陈东, 苏浩, 徐健, 等. 左室心内膜起搏实现心脏再同步化治疗的临床研究[J]. 中华全科医学, 2019, 17(9): 1485-1490. doi: 10.16766/j.cnki.issn.1674-4152.000976

    CHEN D, SU H, XU J, et al. Clinical study of left ventricular endocardial pacing in cardiac resynchronization therapy[J]. Chinese Journal of General Practice, 2019, 17(9): 1485-1490. doi: 10.16766/j.cnki.issn.1674-4152.000976
    [20]
    OLSEN T, JØRGWNSEN O D, NIELSEN J C, et al. Incidence of device-related infection in 97750 patients: clinical data from the complete Danish device-cohort (1982-2018)[J]. Eur Heart J, 2019, 40(23): 1862-1869. doi: 10.1093/eurheartj/ehz316
    [21]
    蔡景景, 乌仁陶古斯, 昃峰, 等. 单中心应用抓捕器Snare拔除电极导线的临床经验[J]. 中国心脏起搏与心电生理杂志, 2019, 33(1): 25-27. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXZ201901006.htm

    CAI J J, WU R T G S, ZE F, et al. The evaluation of Needle's Eye Snare for the extraction of implanted pacemaker leads in a large single-center[J]. Chinese Journal of Cardiac Pacing and Electrophysiology, 2019, 33(1): 25-27. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXZ201901006.htm
    [22]
    STEFAŃCZYK P, NOWOSIELECKA D, TUŁECKI Ł, et al. Transvenous lead extraction without procedure-related deaths in 1000 consecutive patients: a single-center experience[J]. Vasc Health Risk Manag, 2021, 17: 445-459. doi: 10.2147/VHRM.S318205
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (116) PDF downloads(3) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return